These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38332428)

  • 21. Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis.
    Milkiewicz M; Klak M; Kempinska-Podhorodecka A; Wiechowska-Kozlowska A; Urasinska E; Blatkiewicz M; Wunsch E; Elias E; Milkiewicz P
    Sci Rep; 2016 Dec; 6():39573. PubMed ID: 28008998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis.
    Gadaleta RM; Scialpi N; Peres C; Cariello M; Ko B; Luo J; Porru E; Roda A; Sabbà C; Moschetta A
    Sci Rep; 2018 Nov; 8(1):17210. PubMed ID: 30464200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
    Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk.
    Al-Aqil FA; Monte MJ; Peleteiro-Vigil A; Briz O; Rosales R; González R; Aranda CJ; Ocón B; Uriarte I; de Medina FS; Martinez-Augustín O; Avila MA; Marín JJG; Romero MR
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2927-2937. PubMed ID: 29883717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
    J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A.
    Jahn D; Sutor D; Dorbath D; Weiß J; Götze O; Schmitt J; Hermanns HM; Geier A
    Biochim Biophys Acta; 2016 Feb; 1859(2):381-92. PubMed ID: 26723851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids.
    Zhang JH; Nolan JD; Kennie SL; Johnston IM; Dew T; Dixon PH; Williamson C; Walters JR
    Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(10):G940-8. PubMed ID: 23518683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
    Song KH; Li T; Owsley E; Strom S; Chiang JY
    Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Undernutrition Shapes the Gut Microbiota and Bile Acid Profile in Association with Altered Gut-Liver FXR Signaling in Weaning Pigs.
    Lin S; Yang X; Yuan P; Yang J; Wang P; Zhong H; Zhang X; Che L; Feng B; Li J; Zhuo Y; Lin Y; Xu S; Wu D; Burrin DG; Fang Z
    J Agric Food Chem; 2019 Apr; 67(13):3691-3701. PubMed ID: 30864445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
    Stroeve JH; Brufau G; Stellaard F; Gonzalez FJ; Staels B; Kuipers F
    Lab Invest; 2010 Oct; 90(10):1457-67. PubMed ID: 20531290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
    Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
    J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual bile acids have differential effects on bile acid signaling in mice.
    Song P; Rockwell CE; Cui JY; Klaassen CD
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism.
    Cariello M; Piglionica M; Gadaleta RM; Moschetta A
    Handb Exp Pharmacol; 2019; 256():73-93. PubMed ID: 31123830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.